Pfizer and Moderna Stocks: Down 30% and 27% – Buy and Hold by Terry Bingman 06.04.2024 Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...
Medicxi Launches Alys Pharmaceuticals in $100m Seed Funding by Mark Eisenberg 19.02.2024 Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...